Patients undergoing stenting procedures, or cardiac or non-cardiac surgery could develop
myocardial damage as testified by cardiac troponin release.
Sevoflurane (volatile anesthetic), routinely used in cardiac and non-cardiac anesthesia, has
cardioprotective properties that could be useful to reduce cardiac damage, as indicated by
cardiac troponin release in different contexts:
- stenting procedures (periprocedural administration)
- non-cardiac surgery (during the whole procedure)
- cardiac surgery (during the whole procedure)